McCormack F X, Pattanajitvilai S, Stewart J, Possmayer F, Inchley K, Voelker D R
Lord and Taylor Laboratory for Lung Biochemistry, Anna Perahia Adatto Clinical Laboratories, Denver, Colorado 80206, USA.
J Biol Chem. 1997 Oct 31;272(44):27971-9. doi: 10.1074/jbc.272.44.27971.
Rat pulmonary surfactant protein A is an oligomer of 18 polypeptide chains which are associated by triple helix formation in the collagen-like domain and interchain disulfide bridges at the NH2 terminus. The roles of the intermolecular bond at Cys6 and the collagen-like domain (Gly8-Pro80) in the interactions of SP-A with phospholipids and alveolar type II cells were investigated using mutant forms of the protein. Wild type SP-A (SP-Ahyp), SP-A with the substitution Cys6 --> Ser to prevent disulfide formation (SP-Ahyp, C6S), and SP-A with the collagen-domain deleted (SP-ADeltaG8-P80) were synthesized in insect cells using recombinant baculoviruses. The SP-As were glycosylated and secreted from the invertebrate cells and the binding affinities of the wild type and mutant proteins for the mannose-Sepharose matrix used for purification were nearly identical. The SP-Ahyp and SP-ADeltaG8-P80 were at least nonameric in solution based on gel exclusion chromatography, and demonstrated extensive sulfhydryl-dependent oligomerization under nonreducing conditions. The SP-Ahyp,C6S was also oligomeric in solution and formed disulfide-dependent dimers, indicating the presence of at least one additional interchain disulfide bond. The SPADeltaG8-P80 but not the SP-Ahyp,C6S aggregated lipid vesicles at 20 degrees C and augmented the surface tension lowering effect of extracts of natural surfactant. The SP-ADeltaG8-P80 competed poorly with native SP-A for receptor occupancy on isolated alveolar type II cells and was a potent but nonspecific (concanavalin A-like) inhibitor of surfactant secretion. In contrast, the SP-Ahyp,C6S partially competed for receptor occupancy and weakly inhibited surfactant secretion in a specific manner. Neither the SP-ADeltaG8-P80 nor the SP-Ahyp,C6S supported the association of phospholipid liposomes with type II cells. We conclude that: 1) the Cys6 interchain disulfide bond of SP-A is required for aggregation of liposomes and for potent inhibition of surfactant secretion. 2) The collagen-like region is required for competition with 125I-SP-A for receptor occupancy and specific inhibition of surfactant secretion in the presence of competing sugars. 3) Both the NH2-terminal disulfide and the collagen-like region are required to enhance the association of phospholipid vesicles with type II cells.
大鼠肺表面活性蛋白A是由18条多肽链组成的寡聚体,这些多肽链在胶原样结构域中通过三螺旋形成相互关联,并在NH2末端通过链间二硫键相连。利用该蛋白的突变形式研究了Cys6处的分子间键和胶原样结构域(Gly8 - Pro80)在SP - A与磷脂及肺泡II型细胞相互作用中的作用。使用重组杆状病毒在昆虫细胞中合成野生型SP - A(SP - Ahyp)、将Cys6替换为Ser以防止二硫键形成的SP - A(SP - Ahyp,C6S)以及缺失胶原结构域的SP - A(SP - ADeltaG8 - P80)。这些SP - A在无脊椎动物细胞中进行糖基化并分泌,野生型和突变型蛋白对用于纯化的甘露糖 - 琼脂糖基质的结合亲和力几乎相同。基于凝胶排阻色谱法,SP - Ahyp和SP - ADeltaG8 - P80在溶液中至少为九聚体,并且在非还原条件下表现出广泛的巯基依赖性寡聚化。SP - Ahyp,C6S在溶液中也是寡聚体,并形成二硫键依赖性二聚体,表明存在至少一个额外的链间二硫键。SP - ADeltaG8 - P80在20℃时能使脂质囊泡聚集,并增强天然表面活性剂提取物降低表面张力的效果。在分离的肺泡II型细胞上,SP - ADeltaG8 - P80与天然SP - A竞争受体占据的能力较差,并且是表面活性剂分泌的强效但非特异性(伴刀豆球蛋白A样)抑制剂。相比之下,SP - Ahyp,C6S部分竞争受体占据,并以特异性方式微弱抑制表面活性剂分泌。SP - ADeltaG8 - P80和SP - Ahyp,C6S均不支持磷脂脂质体与II型细胞的结合。我们得出以下结论:1)SP - A的Cys6链间二硫键是脂质体聚集和强效抑制表面活性剂分泌所必需的。2)胶原样区域是与125I - SP - A竞争受体占据以及在存在竞争性糖类时特异性抑制表面活性剂分泌所必需的。3)NH2末端二硫键和胶原样区域都是增强磷脂囊泡与II型细胞结合所必需的。